Prognostic role of circulating tumor cells in patients with EGFR‐mutated or ALK‐rearranged non‐small cell lung cancer

BACKGROUND: Circulating tumor cell (CTC) counts at baseline and follow‐up are an independent prognostic factor in patients receiving standard chemotherapy for non‐small cell lung cancer (NSCLC). This study further explored the role of CTCs in EGFR‐mutated and ALK‐rearranged NSCLC patients administer...

全面介紹

Na minha lista:
書目詳細資料
發表在:Thorac Cancer
Main Authors: Tong, Bing, Xu, Yan, Zhao, Jing, Chen, Minjiang, Zhong, Wei, Xing, Jia, Wang, Mengzhao
格式: Artigo
語言:Inglês
出版: John Wiley & Sons Australia, Ltd 2018
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928386/
https://ncbi.nlm.nih.gov/pubmed/29582563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12631
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍